LivaNova (NASDAQ:LIVN) Earns Buy Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of LivaNova (NASDAQ:LIVN – Free Report) in a research report report published on Thursday. The brokerage issued a buy rating on the stock. Other equities analysts have also issued reports about the company. Mizuho raised their price target on LivaNova from $53.00 to $60.00 in a research report on Thursday, […]

Related Keywords

United States ,Hong Kong ,America ,Robertw Baird , ,Associates Corp ,Principal Financial Group Inc ,Intercept Hong Kong Ltd ,America Corp ,Livanova Company Profile ,Barclays ,Victory Capital Management Inc ,Free Report ,Moderate Buy ,Get Free Report ,Financial Group ,Victory Capital Management ,Capital Management ,Advanced Circulatory ,Livanova Daily ,Livanova ,Nasdaq Livn ,Livn ,Medical ,Initiated Coverage ,Stocknews Com ,